Genscript Biotech (HK:1548) has released an update.
Genscript Biotech has appointed Dr. John Anthony Quelch as an independent non-executive director and member of its strategy committee, effective November 14, 2024. Dr. Quelch brings a wealth of experience in global strategy and corporate governance, having held leadership roles in prestigious business schools and serving as a director for various publicly listed companies. This strategic move is expected to enhance Genscript’s governance and strategic planning.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
